HER2/ERBB2 Protein, Human, Recombinant [TMPY-00167]

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

Synonyms	HER-2/neu, erb-b2 receptor tyrosine kinase 2, HER2, HERV7Q, HERVWENV, NEU, CD340, NGL, EGFR2, MLN19, HERV-W-ENV, TKR1, ERVWE1, HERV-7q, MLN 19, HERVW, HER-2, ENV, ENVW
Characteristics	1. Measured by its ability to block anti-ErbB2 mediated inhibition of BT474 human breast ductal carcinoma cell proliferation. The ED50 for this effect is 0.3-1.5 μg/mL in the presence of 0.6 ?g/mL Anti-ErbB2/Her2 Monoclonal Antibody. 2. Immobilized Human Her2/ERBB2 at 2 μg/ml (100 μl/well) can bind Herceptin, the EC50 of Herceptin is 7.0-30.0 ng/mL.
Endotoxin Level	< 1.0 EU/μg of the protein as determined by the LAL method.
Purity	SDS-PAGE: 95.3%; SEC-HPLC: 99.5%
Description	HER2/ERBB2 Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 70 kDa and the accession number is P04626-1.
Reference	Krawczyk N,et al.(2009) HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor. Anticancer Res. 29(10): 4019-24.
URL	https://www.targetmol.com/recombinant-protein/her2_erbb2_protein_human_recombinant_ecd_hplc_verified

バイオ製品Bio Products